Is the generic model enough to fund actual R&D for new medicine? Eg, if generic were legalized everywhere, including the US, and it undercut pharmaceuticals so much that they went out of business, would new drug development cease?
Not that I'm a fan of intellectual property, but I do recognize that there are a few areas where the upfront investment to produce the product is so massive, and copying the final product so easy, that it might make sense to guarantee the profits for a period of time.
Does the pro-generic side have any data or counterpoint to that?
Not that I'm a fan of intellectual property, but I do recognize that there are a few areas where the upfront investment to produce the product is so massive, and copying the final product so easy, that it might make sense to guarantee the profits for a period of time.
Does the pro-generic side have any data or counterpoint to that?